Atlas Trials

Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes

Clinical trial NCT02619565 · COMPLETED

Trial details

NCT number
NCT02619565
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
2010-04-12
Primary completion
2017-06-12
Enrollment
349

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.